109 Aufrufe 109 0 Kommentare 0 Kommentare

    Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences and Enzolytics, Inc. Execute Three Year Agreement

    ALLEN, TX / ACCESSWIRE / September 9, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com") (the "Company") announced today that the Company and the Stephan Angeloff Institute of Microbiology, Department of Immunology, Institute of …

    ALLEN, TX / ACCESSWIRE / September 9, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com") (the "Company") announced today that the Company and the Stephan Angeloff Institute of Microbiology, Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences, represented by Professor Tchorbanov PhD, Head of the Department of Immunology and Penka Petrova PHD, DSc, Director of the Institute of Microbiology, entered into a three year agreement to combine their efforts to accelerate discovery of combined applications and commercialization of their individual entity technologies. The initial focus will be combining Monoclonal Antibodies and Immune Therapeutic Proteins ("ITP") for the development of treatments of malignant antigens. Both companies will work together to conduct future investigations such as pharmacokinetics, pre-clinical and clinical trials.

    The Stephan Angeloff Institute of Microbiology (SAIM) is comprised of a scientific staff of 82 scientists, including 6 professors, 1 academician (Regular member of BAS), 2 corresponding members of Bulgarian Accreditation Service (BAS), 30 associate professors, 61 PhDs, and 7 DSc. The research work of the Institute consists of research projects funded by foreign and Bulgarian grants. Presently, a total of over 30 projects are funded by foreign institutions (FP7 of the EC, Horizon 2020, NATO grants, UNESCO, Institut Pasteur, EEA Norway Grants, the Swiss Government, and by companies abroad), and by the National Science Research Fund at the Ministry of Education and Science, Bulgaria.

    The Department of Immunology within the SAIM is a highly recognized unit performing basic and applied ground-breaking research in immunology. It consists of 3 separate sub-units based on topic and scientific expertise: Laboratory of Infectious Immunology and Inflammation, Laboratory of Experimental Immunotherapy, and Laboratory of Experimental Immunology.

    The Department of Immunology occupies five well-equipped laboratories providing an excellent environment for research based on experimental animal models of diseases (barrier-type SPF animal facility), cell culturing (cell culture room with HEPA clean air filter system and collection of cell lines), flow cytometry, histology and immunohistochemistry, cell signaling and protein purification. The Department of Immunology is included in the Bulgarian National Roadmap for Research Infrastructures (NRRI) and has an official accreditation issued by the National Evaluation and Accreditation Agency to train PhD students. (Source: http://labexpimm.eu)

    Seite 1 von 4




    Accesswire
    0 Follower
    Autor folgen
    Mehr anzeigen
    We’re a newswire service standout and fast becoming an industry disruptor. We provide regional, national and global news to thousands of clients around the world. We’re also leading the way in social engagement, targeting and analytics.
    Mehr anzeigen

    Verfasst von Accesswire
    Department of Immunology, Institute of Microbiology, Bulgarian Academy of Sciences and Enzolytics, Inc. Execute Three Year Agreement ALLEN, TX / ACCESSWIRE / September 9, 2024 / Enzolytics, Inc. (OTC PINK:ENZC) ("enzolytics.com") (the "Company") announced today that the Company and the Stephan Angeloff Institute of Microbiology, Department of Immunology, Institute of …